Eupraxia Pharmaceuticals Inc Capital Reinvestment Ratio

Latest as of March 2020: 0.01x

Eupraxia Pharmaceuticals Inc capital reinvestment ratio. Eupraxia Pharmaceuticals Inc (EPRX) has a Capital Reinvestment Ratio of 0.01x as of March 2020, meaning it reinvests 0% of its operating cash flow (CA$503.92K) in capital expenditures (CA$3.80K). See EPRX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

CA$503.92K

CAD

Capital Expenditures

CA$3.80K

CAD

Data as of

Mar 2020

Most recent filing

Eupraxia Pharmaceuticals Inc Capital Reinvestment Ratio by Year (None–None)

Eupraxia Pharmaceuticals Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Eupraxia Pharmaceuticals Inc operating cash flow efficiency.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow